raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:401768

Proximal myopathy with extrapyramidal signs

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

Proximal myopathy with extrapyramidal signs is a rare, hereditary non-dystrophic myopathy characterized by proximal muscle weakness, delayed motor development, learning difficulties, and progressive extrapyramidal motor signs including chorea, dystonia and tremor. Variable additional features have been reported - ataxia, microcephaly, ophthalmoplegia, ptosis, and optic atrophy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enProximal myopathy with extrapyramidal signs
frMyopathie proximale avec signes extrapyramidaux
deProximale Myopathie mit extrapyramidalen Zeichen
esMiopatía proximal con signos extrapiramidales
itMiopatia prossimale con segni extrapiramidali
nlProximale myopathie met extrapiramidale tekenen
ptMiopatia proximal com sinais extrapiramidais
plMiopatia proksymalna z objawami pozapiramidowymi
csProximální myopatie s extrapyramidovými příznaky
ukПроксимальна міопатія з екстрапірамідними порушеннями
zh近端肌病伴锥体外系体征
trEkstrapiramidal belirtiler ile seyreden proksimal miyopati

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615673Evalidated
ICD-10G71.3NTBTattributedvalidated
MONDO0014300Evalidated
UMLSC4749430Evalidated
GARD12978Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (6):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MICU1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:1530ENSG0000010774560508410q22.1mitochondrial calcium uptake 124336167[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families15 casesWorldwideCase(s)Validated24336167[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_24336167[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

25 annotations · validated 2018-06-20
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012751Abnormal basal ganglia MRI signal intensity
HP:0030230Central core regions in muscle fibers
HP:0003687Centrally nucleated skeletal muscle fibers
HP:0002072Chorea
HP:0009046Difficulty running
HP:0001332Dystonia
HP:0001288Gait disturbance
HP:0001263Global developmental delay
HP:0003557Increased variability in muscle fiber diameter
HP:0004305Involuntary movements
HP:0002310Orofacial dyskinesia
HP:0007153Progressive extrapyramidal movement disorder
HP:0007158Progressive extrapyramidal muscular rigidity
HP:0003701Proximal muscle weakness
HP:0002322Resting tremor
Occasional (29-5%)
HP:0001251Ataxia
HP:0000252Microcephaly
HP:0008180Mildly elevated creatine kinase
HP:0000602Ophthalmoplegia
HP:0000648Optic atrophy
HP:0003477Peripheral axonal neuropathy
HP:0000508Ptosis
Excluded (0%)
HP:0001638Cardiomyopathy
HP:0000365Hearing impairment
HP:0000831Insulin-resistant diabetes mellitus

Annotation source: 24336167[PMID]

7

Sources for this card